查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421546

勃起功能障碍治疗的全球市场 - 热门市场（2024-2029）

Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029
出版日期: | 出版商: Arizton Advisory & Intelligence | 英文 122 Pages | 订单完成后即时交付

价格

勃起功能障碍 (ED) 是指持续或反覆无法维持阴茎勃起以进行令人满意的性活动或性交。ED 通常被称为阳痿，被认为是最常见的男性性健康疾病之一。

2023年，全球勃起功能障碍治疗市场规模为47.2751亿美元，复合年增长率为-0.94%。这一市场规模主要是由勃起功能障碍和相关慢性疾病（如糖尿病、良性前列腺增生、前列腺癌和心血管疾病）患病率上升所推动的，而这些疾病反过来又可能成为该疾病发展的高风险因素。成为勃起功能障碍治疗市场的重要因素。

2023年，北美和欧洲占据市场主导地位，市占率分别为33.63%和29.05%。就预测期内的收入而言，亚太地区预计将成为成长最快的勃起功能障碍治疗市场，复合年增长率为 2.70%。

从产品来看，装备产业以医药产业为主，市占率为79.08%，装备产业市占率为20.92%。然而，在预测期内，设备领域可能会出现最高的增量和绝对成长率，分别为 2.5258 亿美元和 25.54%。

勃起功能障碍药物的给药途径（RoA）细分为口服药物、阴茎注射和外用药物。在这三个细分市场中，由于品牌药物的采用率很高，口服药物占比最大。整体来看，口服药物占92.57%，其次是阴茎注射药物，占4.70%，外用药物占2.73%。

意识的提高、患者寻求医疗援助来治疗和管理疾病的意愿不断增强，以及推荐使用药物和设备治疗勃起功能障碍的有利指南的不断出现，预计将推动预测期内的市场增长。有望促进增长。

该报告研究了全球勃起功能障碍治疗市场，并概述了市场、区域趋势以及参与市场的公司概况。

目录

第一章 勃起功能障碍治疗市场概述

第二章 勃起功能障碍治疗市场

第三章勃起功能障碍治疗市场区隔数据

第四章 主要地区概况

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第五章勃起功能障碍治疗市场前景与机遇

  • 勃起功能障碍治疗市场机会与趋势
  • 勃起功能障碍治疗市场驱动因素
  • 限制勃起功能障碍治疗市场的因素

第六章 勃起功能障碍治疗产业概述

  • 勃起功能障碍治疗市场 - 竞争格局
  • 勃起功能障碍治疗市场－主要供应商概况
  • 勃起功能障碍治疗市场—其他知名供应商
  • 勃起功能障碍治疗市场—关键策略建议

第7章附录

Product Code: AFI23129

REPORT OVERVIEW

This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.

The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

Erectile dysfunction (ED) is the condition that is a persistent or recurrent inability to attain and maintain penile erection sufficient to permit satisfactory sexual activity and intercourse. ED is commonly referred to as impotence and is considered one of the most common male sexual health disorders.

KEY HIGHLIGHTS

  • The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%. The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.
  • In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.
  • Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.
  • The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.
  • Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.
  • Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.

VENDORS LIST

  • Bayer
  • Pfizer
  • Coloplast
  • Eli Lilly and Company
  • Boston Scientific
  • Teva Pharma
  • Viatris
  • Dong-A Socio
  • Vivus
  • Cristalia
  • Dr.Reddy's
  • Aurobindo
  • Seelos Therapeutics
  • Menarini Group
  • GSK plc
  • Futura Medical
  • Sanofi
  • Cipla
  • Lupin
  • Advanz Pharma
  • Sandoz
  • IX Biopharma
  • Domier Medtech
  • Zephyr Surgical Implants
  • Augusta Medical Systems
  • Metuchen Pharmaceuticals
  • SK Chemicals
  • Endo International
  • Ferring Pharmaceuticals
  • Alembic Pharmaceuticals
  • Guangzhou Pharmaceuticals
  • Launch Medical
  • Bonro Medical
  • Owen Mumford
  • Direx Group
  • Zimmer Medizin Systems
  • MTS Medical UG
  • Medispec
  • Inceler Medical
  • NOVAmedtek
  • Wikkon
  • Top Quality Group
  • Promedon
  • Timm Medical Technologies
  • Global Life Technologies
  • Urology Health Store
  • Hims

REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST

  • Product type

Drugs

Route of Administration

    • Oral Drugs
    • Penile Injections
    • Topical Drugs

Distribution Channel

    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Portals

Devices

Type

    • Penile Implants
    • Vacuum Construction Devices
    • Shock Wave Therapy
    • Others

MARKET STRUCTURE

  • Market Dynamics
  • Competitive Landscape of ED Treatment Market
  • Key Vendors
  • Other Prominent Vendors

APPENDIX

  • Research Methodology
  • Abbreviations
  • About Arizton

TABLE OF CONTENTS

CHAPTER - 1: ED Treatment Market Overview

  • Executive Summary
  • Key Findings

CHAPTER - 2: ED Treatment Market

  • GLOBAL: Projected Revenue of ED Treatment Market (2023-2029; $Millions)

CHAPTER - 3: ED Treatment Market Segmentation Data

  • GLOBAL: Projected Revenue by Product type (2022-2028; $ Millions)

Drugs

Route of Administration

    • Oral Drugs
    • Penile Injections
    • Topical Drugs

Distribution Channels

    • Retail Stores
    • Hospital Pharmacies
    • Online Portals

Devices

Type

    • Penile Implants
    • Vacuum Construction Devices
    • Shock Wave Therapy
    • Others

CHAPTER - 4: Key Regions Overview

  • North America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
    • Projected Revenue of ED Treatment Market in US
    • Projected Revenue of ED Treatment Market in Canada
  • Europe: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
    • Projected Revenue of ED Treatment Market in UK
    • Projected Revenue of ED Treatment Market in Germany
    • Projected Revenue of ED Treatment Market in France
    • Projected Revenue of ED Treatment Market in Italy
    • Projected Revenue of ED Treatment Market in Spain
  • APAC: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
    • Projected Revenue of ED Treatment Market in Japan
    • Projected Revenue of ED Treatment Market in China
    • Projected Revenue of ED Treatment Market in India
  • Latin America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
    • Projected Revenue of ED Treatment Market in Brazil
    • Projected Revenue of ED Treatment Market in Mexico
    • Projected Revenue of ED Treatment Market in Argentina
  • Middle East & Africa: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
    • Projected Revenue of ED Treatment Market in Saudi Arabia
    • Projected Revenue of ED Treatment Market in South Africa
    • Projected Revenue of ED Treatment Market in Turkey

CHAPTER - 5: ED Treatment Market Prospects & Opportunities

  • ED Treatment Market Opportunities & Trends
  • ED Treatment Market Drivers
  • ED Treatment Market Constraints

CHAPTER - 6: ED Treatment Industry Overview

  • ED Treatment Market - Competitive Landscape
  • ED Treatment Market - Key Vendor Profiles
  • ED Treatment Market - Other Prominent Vendors
  • ED Treatment Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

  • Research Methodology
  • Abbreviations
  • About Arizton

List Of Exhibits

LIST OF EXHIBITS

Exhibit 1: Projected Revenues of ED Treatment in Global (2023-2029; $ Mn)

Exhibit 2: Projected Revenue of ED Treatment by Drugs (2023-2029; $ Mn)

Exhibit 3: Projected Revenue of ED Treatment by Oral Drugs ($ Mn)

Exhibit 4: Projected Revenues of ED Treatment by Penile Injections (2023-2029; $ Mn)

Exhibit 5: Projected Revenues of ED Treatment by Topical Drugs (2023-2029; $ Mn)

Exhibit 6: Projected Revenues of ED Treatment by Retail Stores (2023-2029; $ Mn)

Exhibit 7: Projected Revenues of ED Treatment by Hospital Pharmacies (2023-2029; $ Mn)

Exhibit 8: Projected Revenues of ED Treatment by Online Portals (2023-2029; $ Mn)

Exhibit 9: Projected Revenue of ED Treatment by Devices (2023-2029; $ Mn)

Exhibit 10: Projected Revenues of ED Treatment by Penile Implants (2023-2029; $ Mn)

Exhibit 11: Projected Revenues of ED Treatment by Vacuum Construction Devices

(2023-2029; $ Mn)

Exhibit 12: Projected Revenues of ED Treatment by Shock Wave Therapy (2023-2029; $ Mn)

Exhibit 13: Projected Revenues of ED Treatment by Others (2023-2029; $ Mn)

Exhibit 14: Projected Revenues of ED Treatment in North America (2023-2029; $ Mn)

Exhibit 15: Projected Revenues of ED Treatment in US (2023-2029; $ Mn)

Exhibit 16: Projected Revenues of ED Treatment in Canada (2023-2029; $ Mn)

Exhibit 17: Projected Revenues of ED Treatment in Europe (2023-2029; $ Mn)

Exhibit 18: Projected Revenues of ED Treatment in UK (2023-2029; $ Mn)

Exhibit 19: Projected Revenues of ED Treatment in Germany (2023-2029; $ Mn)

Exhibit 20: Projected Revenues of ED Treatment in France (2023-2029; $ Mn)

Exhibit 21: Projected Revenues of ED Treatment in Italy (2023-2029; $ Mn)

Exhibit 22: Projected Revenues of ED Treatment in Spain (2023-2029; $ Mn)

Exhibit 23: Projected Revenues of ED Treatment in APAC (2023-2029; $ Mn)

Exhibit 24: Projected Revenues of ED Treatment in Japan (2023-2029; $ Mn)

Exhibit 25: Projected Revenues of ED Treatment in China (2023-2029; $ Mn)

Exhibit 26: Projected Revenues of ED Treatment in India (2023-2029; $ Mn)

Exhibit 27: Projected Revenues of ED Treatment in Latin America (2023-2029; $ Mn)

Exhibit 28: Projected Revenues of ED Treatment in Brazil (2023-2029; $ Mn)

Exhibit 29: Projected Revenues of ED Treatment in Mexico (2023-2029; $ Mn)

Exhibit 30: Projected Revenues of ED Treatment in Argentina (2023-2029; $ Mn)

Exhibit 31: Projected Revenues of ED Treatment in MEA (2023-2029; $ Mn)

Exhibit 32: Projected Revenues of ED Treatment in Saudi Arabia (2023-2029; $ Mn)

Exhibit 33: Projected Revenues of ED Treatment in South Africa (2023-2029; $ Mn)

Exhibit 34: Projected Revenues of ED Treatment in Turkey (2023-2029; $ Mn)

List Of Tables

LIST OF TABLES

Table 1: Key Market Trends in ED Treatment Market

Table 2: Key Market Enablers in ED Treatment Market

Table 3: Key Market Constraints in ED Treatment Market

Table 4: Strategic Recommendations in ED Treatment Market